Stable Id	Screen title	Pubmed Id	Entrez Id	Author-provided gene Id	Assay	Biomodel	Reagent Id	Score type	Score cutoff	Score	Phenotype	Comment
GR00098-A-2	Cell division (2)	17994010	606553	ENSG00000197615	Cell number and DNA content	HeLa	ENSG00000197615_2	Complex, sp	Complex criteria	sp	Cell division defect	
GR00098-A-3	Cell division (3)	17994010	606553	ENSG00000197615	Histone H3 phosphorylation; alpha-tubulin and pericentrin protein expression	HeLa	ENSG00000197615	Mitotic index	>= 2	1.4	none	
GR00098-A-4	Cell division (4)	17994010	606553	ENSG00000197615	Cell size (forward scatter)	HeLa	ENSG00000197615	Cell size	>= 2	-4.6	none	
GR00098-A-1	Cell division (1)	17994010	606553	ENSG00000197615	Cell number and DNA content	HeLa	ENSG00000197615	Complex, sp	Complex criteria	sp	Decreased cell number, increased S DNA content	cell division defect, validated with resynthesized esiRNA
GR00249-S	Vaccinia virus (VACV) infection	23401514	606553	606553	Vaccinia virus VACV IHD-J/GFP protein expression and DNA content	HeLa	s54764	Z-score	>= 1 OR <= -1.5	1.37796	Increased vaccinia virus (VACV) infection	number of cells compared to control (%): 95.40
GR00249-S	Vaccinia virus (VACV) infection	23401514	606553	606553	Vaccinia virus VACV IHD-J/GFP protein expression and DNA content	HeLa	s54765	Z-score	>= 1 OR <= -1.5	-0.74458	none	number of cells compared to control (%): 91.86
GR00249-S	Vaccinia virus (VACV) infection	23401514	606553	606553	Vaccinia virus VACV IHD-J/GFP protein expression and DNA content	HeLa	s54766	Z-score	>= 1 OR <= -1.5	2.61204	Increased vaccinia virus (VACV) infection	number of cells compared to control (%): 86.93
GR00255-A-1	Negative genetic interactions (1)	24104479	606553	11019	shRNA abundance	HCT116	TRCN0000078113,TRCN0000078114,TRCN0000078115,TRCN0000078116	differential Gene Activity Ranking Profile (dGARP)	< -1.0	0.751190666	none	
GR00255-A-2	Negative genetic interactions (2)	24104479	606553	11019	shRNA abundance	HCT116	TRCN0000078113,TRCN0000078114,TRCN0000078115,TRCN0000078116	differential Gene Activity Ranking Profile (dGARP)	< -1.0	-0.141900321	none	
GR00255-A-3	Negative genetic interactions (3)	24104479	606553	11019	shRNA abundance	HCT116	TRCN0000078113,TRCN0000078114,TRCN0000078115,TRCN0000078116	differential Gene Activity Ranking Profile (dGARP)	< -1.2	0.851511212	none	
GR00255-A-4	Negative genetic interactions (4)	24104479	606553	11019	shRNA abundance	HCT116	TRCN0000078113,TRCN0000078114,TRCN0000078115,TRCN0000078116	differential Gene Activity Ranking Profile (dGARP)	< -1.2	0.564112115	none	
GR00255-A-5	Negative genetic interactions (5)	24104479	606553	11019	shRNA abundance	HCT116	TRCN0000078113,TRCN0000078114,TRCN0000078115,TRCN0000078116	differential Gene Activity Ranking Profile (dGARP)	< -0.8	-0.782521507	none	
GR00297-A	Glucose limitation response	24670634	606553		shRNA abundance in high and low glucose	Jurkat	TRCN0000078113	Log2 ratio	< -0.75	0.07	none	
GR00300-A	Combinatorial effect with RAF inhibitor PLX4720	23288408	606553		shRNA abundance	A375	TRCN0000078113,TRCN0000078115,TRCN0000078114,TRCN0000078116	Number of shRNAs ranked Top1000	> 2	0	none	
GR00310-A-1	Sindbis virus (SINV) infection (1)	24367265	606553	606553	Sindbis virus (SINV) reporter	U2OS	np	Z-score	< -3 OR > 2	-0.83	none	
GR00376-A-1	Mitigators of SS1P-induced immunotoxicity	25713356	606553	606553	Viability	KB cells	[object Object]	RSA P-value	<0.001	0.66300243	none	
GR00376-A-2	Sensitizers of SS1P-induced immunotoxicity	25713356	606553	606553	Viability	KB cells	[object Object]	RSA P-value	<0.001	0.118741801	none